Prognostic Stage IV Breast Cancer AJCC v8 Withdrawn Phase 1 Trials for Abemaciclib (DB12001)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04585724Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain MetastasesTreatment